Neurodegenerative Diseases

Annovis Bio Inc. to Host Webcast on Alzheimer’s and Parkinson’s Programs Updates

Annovis Bio Inc. to Host Webcast on Alzheimer’s and Parkinson’s Programs Updates

Annovis Bio Inc. (NYSE: ANVS) is set to host a webcast featuring CEO Maria Maccecchini, Ph.D., to discuss updates on its Phase 3 trial for early Alzheimer’s disease and FDA feedback on its Parkinson’s disease program, highlighting the company's progress in neurodegenerative disease treatments.

June 5, 2025
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease

Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease

A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.

May 30, 2025